Professur für Molekulare Mechanismen der Organfibrose

Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis (2019) Kozlova A, Pachera E, Maurer B, Juengel A, Distler J, Kania G, Distler O Journal article Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial (2019) Highland K, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, et al. Conference contribution Effect of Anti-Topoisomerase I Antibody Status on Decline in Lung Function in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Data from the SENSCIS Trial (2019) Mayes M, Highland K, Gahlemann M, Fischer A, Raghu G, Girard M, Alves M, et al. Conference contribution The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases (2019) Matteson E, Kelly C, Distler J, Mann-Vold AMH, Seibold J, Mittoo S, Distler O, et al. Conference contribution BDCA2 Targeting of Human Plasmacytoid Dendritic Cells via CBS004 Reverts Dependent IFN Activation and Tissue Fibrosis in vitro and in vivo (2019) Ross R, Corinaldesi C, Migneco G, El-Sherbiny Y, Holmes S, Distler J, Mckimmie C, Del Galdo F Conference contribution Cracking a Novel Profibrotic Molecular Mechanism: lncRNA H19X and DDIT4L Crosstalk (2019) Pachera E, Assass S, Salazar G, Frank-Bertoncelj M, Distler J, Kania G, Distler O Conference contribution Hsp90 as a Potential Biomarker of Lung and Skin Involvement in Patients with Systemic Sclerosis (2019) Storkanova H, Oreska S, Spiritovic M, Hermankova B, Bubova K, Komarc M, Pavelka K, et al. Conference contribution The Effect of Nintedanib versus Mycopheolate Mofetil in the FRA2 Mouse Model of Systemic Sclerosis Associated Interstitial Lung Disease (2019) Thuong Trin-Minh , Zhang Y, Distler J, Wollin L Conference contribution EFFICACY OF WNT PATHWAY INHIBITORS FOR THE PREVENTION OF CARDIAC ALLOGRAFT VASCULOPATHY IN A MOUSE MODEL (2019) Kuckhahn A, Ramsperger-Gleixner M, Distler J, Spriewald B, Ensminger S, Weyand M, Heim C Conference contribution Does anti-acid treatment influence disease progression in SSc-ILD ? data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution